Cinemark Stock Forecast, Price & News

Cinemark (NYSE:CNK) Frequently Asked Questions

Is Cinemark a buy right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cinemark in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Cinemark stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNK, but not buy additional shares or sell existing shares.
View analyst ratings for Cinemark or view top-rated stocks.

What stocks does MarketBeat like better than Cinemark?

Wall Street analysts have given Cinemark a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cinemark wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Cinemark's next earnings date?

Cinemark is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Cinemark.

How were Cinemark's earnings last quarter?

Cinemark Holdings, Inc. (NYSE:CNK) released its quarterly earnings data on Thursday, August, 5th. The company reported ($1.19) EPS for the quarter, missing the consensus estimate of ($1.13) by $0.06. The firm earned $294.70 million during the quarter, compared to analysts' expectations of $260.98 million. Cinemark had a negative trailing twelve-month return on equity of 107.71% and a negative net margin of 135.90%. The firm's revenue was up 3174.4% on a year-over-year basis. During the same period in the previous year, the company earned ($1.45) EPS.
View Cinemark's earnings history.

How has Cinemark's stock been impacted by Coronavirus?

Cinemark's stock was trading at $19.49 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CNK stock has increased by 3.5% and is now trading at $20.18.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CNK?

8 brokers have issued 1 year price objectives for Cinemark's stock. Their forecasts range from $14.00 to $31.00. On average, they anticipate Cinemark's stock price to reach $24.00 in the next year. This suggests a possible upside of 18.9% from the stock's current price.
View analysts' price targets for Cinemark or view top-rated stocks among Wall Street analysts.

Who are Cinemark's key executives?

Cinemark's management team includes the following people:

• Mark Zoradi, Chief Executive Officer & Director
• Sean Gamble, President, Chief Operating & Financial Officer
• Damian Wardle, Executive VP-Theatre & Technology Operations
• Doug Fay, Senior Vice President-Information Technology
• Michael D. Cavalier, Secretary, Executive VP & General Counsel

What is Mark Zoradi's approval rating as Cinemark's CEO?

295 employees have rated Cinemark CEO Mark Zoradi on Glassdoor.com. Mark Zoradi has an approval rating of 73% among Cinemark's employees.

Who are some of Cinemark's key competitors?

Some companies that are related to Cinemark include The Walt Disney (DIS), Live Nation Entertainment (LYV), News (NWSA), World Wrestling Entertainment (WWE) and Reading International (RDI).
View all of CNK's competitors.

What other stocks do shareholders of Cinemark own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cinemark investors own include Pfizer (PFE), Carnival Co. & (CCL), AT&T (T), Wells Fargo & Company (WFC), AMC Entertainment (AMC), Southwest Airlines (LUV), Tesla (TSLA), Exxon Mobil (XOM), Delta Air Lines (DAL) and Intel (INTC).

What is Cinemark's stock symbol?

Cinemark trades on the New York Stock Exchange (NYSE) under the ticker symbol "CNK."

Who are Cinemark's major shareholders?

Cinemark's stock is owned by a variety of retail and institutional investors. Top institutional investors include Hodges Capital Management Inc. (0.67%), State of Alaska Department of Revenue (0.06%), Louisiana State Employees Retirement System (0.04%) and First Dallas Securities Inc. (0.02%). Company insiders that own Cinemark stock include Lee Roy Mitchell, Mark Zoradi, Michael Cavalier, Valmir Fernandes and Ximena G Humrichouse.
View institutional ownership trends for Cinemark.

Which major investors are buying Cinemark stock?

CNK stock was bought by a variety of institutional investors in the last quarter, including Hodges Capital Management Inc., State of Alaska Department of Revenue, Louisiana State Employees Retirement System, and First Dallas Securities Inc.. Company insiders that have bought Cinemark stock in the last two years include Lee Roy Mitchell, Mark Zoradi, and Ximena G Humrichouse.
View insider buying and selling activity for Cinemark or or view top insider-buying stocks.

How do I buy shares of Cinemark?

Shares of CNK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cinemark's stock price today?

One share of CNK stock can currently be purchased for approximately $20.18.

How much money does Cinemark make?

Cinemark has a market capitalization of $2.41 billion and generates $686.31 million in revenue each year. The company earns $-616.83 million in net income (profit) each year or ($5.25) on an earnings per share basis.

How many employees does Cinemark have?

Cinemark employs 18,000 workers across the globe.

What is Cinemark's official website?

The official website for Cinemark is www.cinemark.com.

Where are Cinemark's headquarters?

Cinemark is headquartered at 3900 DALLAS PARKWAY, PLANO TX, 75093.

How can I contact Cinemark?

Cinemark's mailing address is 3900 DALLAS PARKWAY, PLANO TX, 75093. The company can be reached via phone at (972) 246-3627 or via email at [email protected].